Search Within

Allyson Marie Flower

Formats
  1. Meeting Abstract (8)
  2. Research Letter (1)
Groups
  1. Pediatrics, Department of (9)
  2. Biostatistics Service (1)
  3. Epidemiology and Biostatistics (1)
  4. Hematologic Malignancies Service (1)
  5. Sloan Kettering Institute Postdocs (1)
  6. Stem Cell Transplantation and Cellular Therapy Service (1)
People
  1. Audrey Mauguen (1)
  2. Jessica Stiefel (1)
  3. Kevin Curran (1)
  4. Maria Luisa Sulis (1)
Years
  1. 2023 (1)
  2. 2022 (8)
Publications
  1. Pediatric Blood and Cancer (3)
  2. Transplantation and Cellular Therapy (3)
  3. Blood (1)
  4. Leukemia Research (1)
  5. Leukemia and Lymphoma (1)
Publishers
  1. Elsevier Inc. (3)
  2. Wiley Periodicals, Inc (3)
  3. American Society of Hematology (1)
  4. Elsevier Ltd (1)
  5. Taylor & Francis Group (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma
    Research Letter

    Gardenswartz, A.; Mehta, B.; El-Mallawany, N. K.; van de Ven, C.; Hochberg, J.; Flower, A.; Morris, E.; Harrison, L.; Chu, Y.; Basso, J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • A phase I trial of targeted immunotherapy with daratumumab following myeloablative total body irradiation (TBI)-based conditioning and allogeneic hematopoietic cell transplantaton in children, adolescents and young adults with high-risk T-cell acute lymphoblastic leukemia and lymphoma (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC facilitated study
    Meeting Abstract

    Quigg, T.; Flower, A.; Teachey, D.; Lim, M.; Chu, Y.; Harrison, L.; Morris, E.; Gardenswartz, A.; Hochberg, J.; Ozkaynak, M.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Antigen directed therapy pre-transplant confers superior post-transplant survival outcome compared to conventional chemotherapy in pediatric patients with relapsed and refractory B-ALL
    Meeting Abstract

    Stiefel, J.; Flower, A. M.; Botwinick, M.; Ford, M.; Foti, A.; Gandhi, M.; Slovin, J.; Smilow, E.; Bowers, A.; Karpel, H.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Haploidentical viral specific cytotoxic T-lymphocytes (VCTLS) for the treatment of refractory viral infections in primary immunodeficiency (PID), solid organ (SOT) or allogeneic BMT patients
    Meeting Abstract

    Talano, J.; Milner, J.; Harrison, L.; Ayello, J.; Flower, A.; Chu, Y.; Johnson, B.; Li, Y.; Lee, D.; Chu, J.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of high dose granulocyte colony stimulating factor mobilization in familial haploidentical adult donors with sickle cell trait followed by CD34+ cell enrichment and mononuclear cell add-back prior to haploidentical allogeneic transplantation in high-risk sickle cell disease recipients
    Meeting Abstract

    Milner, J.; Flower, A.; Schulman, S.; Keever-Taylor, C. A.; Fabricatore, S.; Morris, E.; Mahanti, H.; Shi, Q.; Shaw, R.; Weinberg, R. S.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Feasibility, safety and efficacy of haploidentical viral cytotoxic T-lymphocytes for children, adolescents, and young adults (CAYA) with refractory viral infections in primary immunodeficiencies (PID) post solid organ transplant (SOT) or allogeneic hematopoietic stem cell transplantation (AlloHSCT)
    Meeting Abstract

    Milner, J.; Talano, J. A.; Harrison, L.; Ayello, J.; Flower, A.; Chu, Y.; Rigot, O.; Johnson, B. D.; Li, Y.; Lee, D. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Determining the safety and efficacy of prophylactic defibrotide administration in children, adolescents, and young adults with high-risk sickle cell disease (SCD) or beta thalassemia major following myeloimmunoablative conditioning (MAC) and haploidentical stem cell transplantation utilizing CD34+ selection and T-cell (CD3) addback (IND127812)
    Meeting Abstract

    Schaefer, E.; Milner, J.; Hung, J.; Ayello, J.; Shi, Q.; Talano, J. A.; Moore, T. B.; Friedman, D.; Dozor, A. J.; Klejmont, L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of dose escalation of defibrotide in hematopoietic stem cell transplantation (HSCT) recipients with sinusoidal obstructive syndrome (SOS) refractory to standard treatment doses of defibrotide
    Meeting Abstract

    Friedmann, R.; Milner, J.; Flower, A.; Harrison, L.; Klejmont, L.; Morris, E.; Van de Ven, C.; Vegunta, R.; Cooke, K. R.; Cairo, M. S.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Treating children, adolescents, and young adults (CAYA) with refractory viral infections in primary immunodeficiencies (PID), or post solid organ transplant (sot) or allogeneic hematopoietic stem cell transplantation (AlloHSCT) with virus specific tlymphocytes (vCTLs)
    Meeting Abstract

    Milner, J.; Talano, J. A.; Harrison, L.; Ayello, J.; Flower, A.; Chu, Y.; Rigot, O.; Johnson, B. D.; Li, Y.; Lee, D. A.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save